SEC Filing Details

Document Details

Form
Filing Date
10/21/2013
Document Date
10/21/2013
Form Description
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Filing Group
Registration Statements
Company
Eagle Pharmaceuticals, Inc.
Issuer
EAGLE PHARMACEUTICALS, INC.